April 30, 2019

Lilly scraps two research assets, leaving few rivals behind

September 17, 2018

Tyk2 reaches tipping point

Bristol-Myers Squibb is ahead in a new oral class that could bring similar efficacy to current injectables for autoimmune diseases – but Pfizer seems less keen.

October 01, 2014

Therapy focus – Leukaemia opportunity gives FLT a chance to take flight

August 09, 2011

Therapeutic focus - Roche places big bet on novel chemotherapy enhancers